<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04204863</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00693; me19Sutter5</org_study_id>
    <nct_id>NCT04204863</nct_id>
  </id_info>
  <brief_title>Status Epilepticus Unicenter Population (STEP UP) Study</brief_title>
  <acronym>STEP UP</acronym>
  <official_title>Status Epilepticus Unicenter Population (STEP UP) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this observational single-center cohort study is to gain a deeper understanding
      regarding the effects of treatment adaption based on information from outcome prediction
      models, risk stratification, as well as treatment monitoring, detection, prevention, and
      management of complications on course and outcome of adult patients with status epilepticus
      (SE).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Demographics</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>age, sex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data from acute prehospital management by the emergency medical services (EMS)</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>extracted from the treatment protocols of the EMS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of ICU (intensive care unit) and hospital stay, and destination at discharge</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Duration of ICU (intensive care unit) and hospital stay, and destination at discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Date(s) of seizure(s) captured by electroencephalographic (EEG) data</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Date(s) of seizure(s) captured by EEG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seizure history and etiology</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>withdrawal from anti seizure drugs, structural, infectious, or autoimmune causes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number and Duration of SE episodes</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Number and Duration (time) of SE episodes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Types of SE</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Types of SE according to the current guidelines from the International League of Epilepsy (ILAE) (i.e., nonconvulsive with coma, SE with motor symptoms, focal nonconvulsive SE without coma, and subtle SE</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Additional features of the seizure</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>length, level of consciousness at onset, previous epileptic seizures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU Scoring Systems</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Critical illness severity scores (e.g., acute physiology and chronic health Evaluation (APACHE II), simplified acute physiology score (SAPS II), sequential organ failure assessment (SOFA), etc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical neurologic monitoring scores</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>Clinical neurologic monitoring scores (e.g., Richmond Agitation-Sedation Scale (RASS) , Seda-tion-Agitation Scale (SAS), Glasgow Coma Score (GCS), Intensive Care Delirium Screening Checklist (ICDSC), Status Epilepticus Severity Score (STESS))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>C-Reactive Protein (CRP), albumin, Lactate Dehydrogenase (LDH), Creatin-Kinase (CK), procalcitonin, white blood cell levels, creatinine, liver enzymes, blood gas analyses, metabolic data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome measure</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>in-hospital death, survival, survival with neurofunctional alteration, Glasgow Outcome Score, return to neurofunctional premorbid baseline, readmission</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Therapeutic features</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>duration, dosage and number of treatment medication, number of antiseizure drugs, invasive procedures, such as intubation, mechanical, ventilation, vasopressors, installation of central lines, nutrition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monitoring of vital signs</measure>
    <time_frame>between 01.01.2005 and 19.12.2018</time_frame>
    <description>blood pressure, heart rate, respiratory rate, oxygen saturation of the blood, body temperature, level of consciousness</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Epileptic Seizures</condition>
  <arm_group>
    <arm_group_label>SE patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of patient data</intervention_name>
    <description>Extract data from the digital medical records, the electroencephalographic and microbiologic database.</description>
    <arm_group_label>SE patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2018
        who have been treated at the University Hospital of Basel.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and
             2018 who have been treated at the University Hospital of Basel.

        Exclusion Criteria:

          -  Patients younger than 18 years.

          -  Patients with repetitive epileptic seizures not qualifying for SE.

          -  Patients with documented refusal of the general consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raoul Sutter, PD Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Intensive Care Medicine, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raoul Sutter, PD Dr. med</last_name>
    <phone>+41 61 265 25 25</phone>
    <email>Raoul.Sutter@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saskia Semmlack, Dr. med</last_name>
    <phone>+41 61 55 65575</phone>
    <email>Saskia.Semmlack@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for Intensive Care Medicine, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raoul Sutter, PD Dr. med</last_name>
      <phone>+41 61 265 25 25</phone>
      <email>raoul.sutter@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Saskia Semmlack, Dr. med</last_name>
      <phone>+41 61 55 65575</phone>
      <email>Saskia.Semmlack@usb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Sarah Tschudin-Sutter, Prof. Dr. med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sira Baumann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 17, 2019</study_first_submitted>
  <study_first_submitted_qc>December 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>December 17, 2019</last_update_submitted>
  <last_update_submitted_qc>December 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Status epilepticus</keyword>
  <keyword>Electroencephalogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Status Epilepticus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

